Tag: atrial fibrillation

1. In patients with recent ischemic stroke and no diagnosed atrial fibrillation (AF), there were increased AF diagnoses in those who received an implantable loop recorder compared with those who received an external loop recorder within 12 months of the intervention. Evidence Rating Level: 1 (Excellent) Study Rundown: Atrial fibrillation (AF)...
1. Roughly 33.8% of patients with atrial fibrillation and/or venous thromboembolism undergoing treatment with a direct oral anticoagulant (DOAC) were also being treated with aspirin without a clear indication. 2. Patients being treated with DOAC and aspirin experienced significantly more bleeding events and hospitalizations, compared to DOAC monotherapy. Evidence Rating Level:...
1. In patients treated with direct oral anticoagulants (DOACs) for atrial fibrillation or venous thromboembolism (VTE), adding aspirin (ASA) was associated with increased bleeding events. 2. Adding ASA to DOAC treatment for patients with atrial fibrillation or VTE did not improve the incidence of thrombotic events. Evidence Rating Level: 2 (Good) Study Rundown: Aspirin...
1. Patients who received a direct oral anticoagulant had a lower risk of thromboembolic events and major bleeds compared to patients who received warfarin. 2. The between-group differences were consistent across all prespecified clinically relevant subgroups. Evidence Rating Level: 2 (Good) Study Rundown: It is recommended for patients with atrial fibrillation to...
1. Direct oral anticoagulants may have a superior risk-benefit profile compared to vitamin K antagonists in atrial fibrillation for patients with hemodialysis. Evidence Rating Level: 2 (Good) While direct oral anticoagulants (DOACs) have been shown to have superior risk-benefit profiles over vitamin K antagonists (VKAs) in patients with atrial fibrillation and normal...
1. Direct oral anticoagulants may have a superior risk-benefit profile compared to vitamin K antagonists in atrial fibrillation for patients with hemodialysis. Evidence Rating Level: 2 (Good) While direct oral anticoagulants (DOACs) have been shown to have superior risk-benefit profiles over vitamin K antagonists (VKAs) in patients with atrial fibrillation and...
1. The C2HEST score had moderate accuracy in predicting sustained atrial high-rate episodes (SAHREs) for patients with cardiac implantable electronic devices, but no atrial fibrillation. 2. A 1-point increase in the C2HEST score was associated with a 39% increased risk of SAHREs). Evidence Rating Level: 2 (Good) In patients without atrial fibrillation...
1. Low to moderate alcohol intake was not significantly associated with risk of stroke or other cardiovascular outcomes in patients with atrial fibrillation. Evidence Rating Level: 2 (Good) “Holiday heart syndrome” describes the association found between excessive alcohol intake and incidence of atrial arrhythmias. Even low amounts of regular alcohol intake...
Evidence Rating Level: 2 (Good) 1. Preoperative levels of brain-type natriuretic peptide were independently associated with postoperative atrial fibrillation risk after noncardiac surgery. Postoperative atrial fibrillation (POAF) after noncardiac surgery has been associated with prolonged hospital stays and an increased risk of stroke and death. As an established marker in heart...
1. Patients who received rivaroxaban had a statistically significantly longer mean time until occurrence of a major clinical event compared to those who received warfarin. 2. The incidence of secondary-outcome events such as transient ischemic attack (TIA), valve thrombosis, and non-CNS embolism were similar between groups. Evidence Rating Level: 1 (Excellent) Study...